Correction to: Population pharmacokinetics of PF‑05280014 (a trastuzumab biosimilar) and reference trastuzumab (Herceptin(®)) in patients with HER2‑positive metastatic breast cancer

Detalles Bibliográficos
Autores principales: Chen, Xiaoying, Li, Cheryl, Ewesuedo, Reginald, Yin, Donghua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2019
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6682847/
https://www.ncbi.nlm.nih.gov/pubmed/31292683
http://dx.doi.org/10.1007/s00280-019-03890-7
_version_ 1783441959932657664
author Chen, Xiaoying
Li, Cheryl
Ewesuedo, Reginald
Yin, Donghua
author_facet Chen, Xiaoying
Li, Cheryl
Ewesuedo, Reginald
Yin, Donghua
author_sort Chen, Xiaoying
collection PubMed
description
format Online
Article
Text
id pubmed-6682847
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-66828472019-08-19 Correction to: Population pharmacokinetics of PF‑05280014 (a trastuzumab biosimilar) and reference trastuzumab (Herceptin(®)) in patients with HER2‑positive metastatic breast cancer Chen, Xiaoying Li, Cheryl Ewesuedo, Reginald Yin, Donghua Cancer Chemother Pharmacol Correction Springer Berlin Heidelberg 2019-07-10 2019 /pmc/articles/PMC6682847/ /pubmed/31292683 http://dx.doi.org/10.1007/s00280-019-03890-7 Text en © The Author(s) 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Correction
Chen, Xiaoying
Li, Cheryl
Ewesuedo, Reginald
Yin, Donghua
Correction to: Population pharmacokinetics of PF‑05280014 (a trastuzumab biosimilar) and reference trastuzumab (Herceptin(®)) in patients with HER2‑positive metastatic breast cancer
title Correction to: Population pharmacokinetics of PF‑05280014 (a trastuzumab biosimilar) and reference trastuzumab (Herceptin(®)) in patients with HER2‑positive metastatic breast cancer
title_full Correction to: Population pharmacokinetics of PF‑05280014 (a trastuzumab biosimilar) and reference trastuzumab (Herceptin(®)) in patients with HER2‑positive metastatic breast cancer
title_fullStr Correction to: Population pharmacokinetics of PF‑05280014 (a trastuzumab biosimilar) and reference trastuzumab (Herceptin(®)) in patients with HER2‑positive metastatic breast cancer
title_full_unstemmed Correction to: Population pharmacokinetics of PF‑05280014 (a trastuzumab biosimilar) and reference trastuzumab (Herceptin(®)) in patients with HER2‑positive metastatic breast cancer
title_short Correction to: Population pharmacokinetics of PF‑05280014 (a trastuzumab biosimilar) and reference trastuzumab (Herceptin(®)) in patients with HER2‑positive metastatic breast cancer
title_sort correction to: population pharmacokinetics of pf‑05280014 (a trastuzumab biosimilar) and reference trastuzumab (herceptin(®)) in patients with her2‑positive metastatic breast cancer
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6682847/
https://www.ncbi.nlm.nih.gov/pubmed/31292683
http://dx.doi.org/10.1007/s00280-019-03890-7
work_keys_str_mv AT chenxiaoying correctiontopopulationpharmacokineticsofpf05280014atrastuzumabbiosimilarandreferencetrastuzumabherceptininpatientswithher2positivemetastaticbreastcancer
AT licheryl correctiontopopulationpharmacokineticsofpf05280014atrastuzumabbiosimilarandreferencetrastuzumabherceptininpatientswithher2positivemetastaticbreastcancer
AT ewesuedoreginald correctiontopopulationpharmacokineticsofpf05280014atrastuzumabbiosimilarandreferencetrastuzumabherceptininpatientswithher2positivemetastaticbreastcancer
AT yindonghua correctiontopopulationpharmacokineticsofpf05280014atrastuzumabbiosimilarandreferencetrastuzumabherceptininpatientswithher2positivemetastaticbreastcancer

Ejemplares similares